Fidus Investment Corporation Announces Fourth Quarter and Full Year 2025 Financial Results
Globenewswire· 2026-02-26 21:05
Board of Directors Declared Total Dividends of $0.52 per Share for First Quarter 2026 Base Dividend of $0.43 and Supplemental Dividend of $0.09 Per Share EVANSTON, Ill., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Fidus Investment Corporation (NASDAQ:FDUS) (“Fidus” or the “Company”), a provider of customized debt and equity financing solutions, primarily to lower middle-market companies based in the United States, today announced its financial results for the fourth quarter and full year ended December 31, 2025. Four ...
OrthoPediatrics Corp. Reports Fourth Quarter and Full Year 2025 Financial Results
Globenewswire· 2026-02-26 21:05
Record full year 2025 revenue of $236.3 million increased 15% compared to prior yearOperating Cash flow improvement of $22 million in full year 2025Generated $10 million of free cash flow in the fourth quarter, the first quarter of positive free cash flow in Company history WARSAW, Ind., Feb. 26, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced its financial resu ...
Seer Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Full Year 2026 Outlook
Globenewswire· 2026-02-26 21:05
REDWOOD CITY, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today reported financial results for the fourth quarter and full year ended December 31, 2025. Recent Highlights Generated revenue of $4.2 million for the fourth quarter of 2025 and $16.6 million for the full year 2025Expanded installed base to 82 instruments, representing 67% year-over-year growth, with 33 total instruments installed during the full year ...
TTEC Announces Fourth Quarter and Full Year 2025 Financial Results
Globenewswire· 2026-02-26 21:05
Core Insights - TTEC Holdings, Inc. reported a net loss of $170.5 million in Q4 2025, primarily due to a non-cash goodwill impairment charge of $205.4 million, despite a slight revenue increase of 0.4% to $570.0 million [2][4][9] - For the full year 2025, the company experienced a revenue decline of 3.2% to $2.137 billion, with a net loss of $185.1 million, although non-GAAP net income was $52.8 million, representing 2.5% of revenue [3][4][13] - The company is optimistic about 2026, projecting revenue between $2.005 billion and $2.055 billion, with a focus on improving EBITDA and operating income margins [19][20] Financial Performance - Q4 2025 revenue was $570.0 million, up 0.4% from $567.4 million in Q4 2024, with a positive foreign exchange impact of $4.0 million [9] - Adjusted EBITDA for Q4 2025 was $62.2 million, or 10.9% of revenue, compared to $50.9 million, or 9.0% of revenue in the prior year [8][9] - Full year 2025 adjusted EBITDA was $213.7 million, or 10.0% of revenue, an increase from $202.3 million, or 9.2% of revenue in 2024 [11][13] Segment Performance - TTEC Digital reported Q4 2025 revenue of $125.5 million, a 9.2% increase year-over-year, but faced a significant loss from operations of $200.0 million [21] - TTEC Engage had Q4 2025 revenue of $444.5 million, a 1.8% decrease from the previous year, but improved its income from operations to $27.4 million, or 6.2% of revenue [21] Cash Flow and Balance Sheet - Cash flow from operations in Q4 2025 was positive at $2.6 million, a recovery from a negative $1.1 million in Q4 2024, with full year cash flow from operations at $121.1 million compared to a negative $58.8 million in 2024 [14] - As of December 31, 2025, TTEC had cash and cash equivalents of $82.9 million and total debt of $908.0 million, resulting in a net debt position of $825.1 million [14][15] Business Outlook - The company aims to enhance its EBITDA and operating income in 2026, with a commitment to higher value transformational engagements across its segments [19][20] - TTEC's guidance for 2026 includes projected revenue of $2.030 billion and non-GAAP adjusted EBITDA of $230 million, indicating a focus on margin expansion [20][22][23]
Zumiez Inc. to Report Fiscal 2025 Fourth Quarter and Full Year Results
Globenewswire· 2026-02-26 21:05
LYNNWOOD, Wash., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Zumiez Inc. (NASDAQ: ZUMZ) today announced it will report fiscal 2025 fourth quarter and full year results on Thursday, March 12, 2026, following the closing of regular stock market trading hours. The Company will hold a conference call that day at 5:00 p.m. ET to review the results. To access the conference call, please pre-register using this link (Registration Link). Registrants will receive confirmation with dial-in details. The conference call will als ...
Castle Biosciences Reports Fourth Quarter and Full–Year 2025 Results
Globenewswire· 2026-02-26 21:05
2025 total test reports for our core revenue drivers (DecisionDx®-Melanoma, TissueCypher®) increased 37% over 2024 Exceeded 2025 guidance with full-year revenue of $344 million Conference call and webcast today at 4:30 p.m. ET FRIENDSWOOD, Texas, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced its financial results for the fourth quarter and year ended Dec. 31, 2025.“We closed out an outst ...
Cytek Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Outlook
Globenewswire· 2026-02-26 21:05
FREMONT, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Cytek® Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), a leading cell analysis solutions company, today reported financial results for the fourth quarter and year ended December 31, 2025. Fourth Quarter and Full Year 2025 Highlights Total revenue for the fourth quarter was $62.1 million, an 8% increase compared to the fourth quarter of 2024, and the highest quarterly revenue achieved historically at CytekTotal revenue for the full year 20 ...
Zscaler Announces Strong Second-Quarter Fiscal 2026 Results; Raises Fiscal 2026 ARR Guidance to 24%
Globenewswire· 2026-02-26 21:05
Exceeds high-end of second-quarter guidance on revenue and profitability metrics Second Quarter Highlights Revenue grew 26% year-over-year to $815.8 millionAnnual Recurring Revenue ("ARR") grew 25% year-over-year to $3,359 millionOperating cash flow grew 14% year-over-year to $204.1 millionFree cash flow grew 18% year-over-year to $169.1 million SAN JOSE, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Zscaler, Inc. (Nasdaq: ZS), the leader in cloud security, today announced financial results for its second quart ...
AVAX One to Participate at the Citizens Technology Conference on March 2, 2026
Globenewswire· 2026-02-26 21:05
WEST PALM BEACH, FL, Feb. 26, 2026 (GLOBE NEWSWIRE) -- AVAX One Technology Ltd. (Nasdaq: AVX) (“AVAX One” or the "Company"), today announced its participation at the upcoming Citizens Technology Conference being held March 2-3, 2026 at the Ritz-Carlton hotel in San Francisco, CA. AVAX One’s management team will host 1x1 investor meetings throughout the day on Monday, March 2, 2026. The Company will also participate in the “Digital Asset Treasuries: Creating Value Beyond Spot Exposure” panel at 1:00 PM PT on ...
Clover Health Reports Fourth Quarter & Full Year 2025 Results; Provides Full Year 2026 Guidance
Globenewswire· 2026-02-26 21:05
Business Highlights: Generated full year 2025 Adjusted EBITDA profitability while growing membership by 38% and Insurance revenue by 41% year-over-yearAchieved industry-leading 2026 AEP growth of 53% year-over-year with strong returning member retentionExpect improving cohort economics powered by Clover Assistant to drive our first-ever full year of GAAP Net Income profitability in 2026 Financial Results: Full year 2025 Medicare Advantage membership of 113,803, up 38% year-over-yearFull year 2025 Total reve ...